{
    "nctId": "NCT00772824",
    "briefTitle": "Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients",
    "officialTitle": "Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients- A Prospective, Randomised, Single Blind, Three Arm, Phase Four Prevention Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 23,
    "primaryOutcomeMeasure": "Reduction in toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* The patients \\> 18 years of age\n* Histologically or cytologically proven breast cancer\n* Receiving CEF chemotherapy cycles presently or in the past\n* The patients who will give informed consent to participate in the study\n* Patients must have sufficient organ and marrow function\n* Stage 1 neuropathy, subclinical neuropathy, surgery induced neuropathy\n\nExclusion Criteria:\n\n* Pregnancy\n* Clinical/biochemical severe liver failure\n* Clinical/biochemical severe renal dysfunction\n* Refusal to participate in the study\n* Patients who have received prior chemotherapy with paclitaxel.\n* Patients who have neuropathy due to any known systemic or metabolic causes like diabetes, leprosy, nutritional deficiency induced (vit. B12) etc",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}